MEDIA ADVISORY - October 21, 2009
PRESENTATION OF VERILOGUE DATA AT UPCOMING EYE FOR PHARMA CONFERENCE REVEALS HOW TO IDENTIFY AND OVERCOME PATIENT ADHERENCE CHALLENGES
Data to Showcase Insights on Patient Adherence Derived from Verilogue Analysis of In-Office Patient-Physician Dialogue
| WHO: | Jeffrey Dierks, Senior Product Director, Endo Pharmaceuticals |
| WHAT: |
"Adherence as part of a commercial strategy: How to create value through communication and co-ordination, leading to better relationships with patients"
This presentation will include information that demonstrates how the analysis of real-life, in-office dialogue between patients and physicians is critical to revealing concrete and specific recommendations for improving patient adherence. Using real-world examples from Verilogue's Nationwide Point-of-Practice database, the presentation will highlight conversations between physicians and patients around two of the most challenging patient adherence categories - pain management and diabetes - to illustrate how brand teams can adjust marketing efforts to overcome the adherence challenge. Through the analysis of patient-physician dialogue, attendees will learn not only how to identify the three stages of adherence, but also how to improve delivery of critical information relating to patient adherence and ultimately improve the patient-physician relationship. |
| WHEN: | Monday, October 26, 2009, 11:30-12:15 p.m. ET |
| WHERE: | Eye for Pharma's Patient Adherence & Engagement Summit to be held October 26-27, 2009 in Philadelphia. This year's conference will emphasize the core issues affecting patient adherence and collectively voice ideas and initiatives that could boost adherence levels. |
| SHARE: | Tweet this: Overcome the patient adherence challenge with Verilogue data of real-life in-office patient-physician dialogue. |
About Verilogue
Verilogue (www.verilogue.com) is the first health care market research company to uncover, analyze and deliver nationwide insights derived from naturally-occurring dialogue between patients and physicians. With its patent-pending Point-of-Practice™ database and technology system, which digitally records real-time conversations between patients and physicians, Verilogue is able to capture critical information at the point of care, while maintaining patient and physician confidentiality. The insights gathered from these conversations, analyzed by Verilogue's team of linguists, statisticians and marketing experts, enable pharmaceutical and health care companies to gain a deeper understanding of patient and physician perspectives, help shape conversations that affect health care decisions, identify the most effective methods and tools to reach patients and drive the development and improvement of new and existing treatments to ultimately improve patient care.
More than 25 pharmaceutical companies have partnered with Verilogue to gain actionable insights from its database containing 30,000+ unique physician-patient conversations and corresponding patient charts across 50+ therapeutic categories. Founded in 2006, Verilogue is a privately-held company headquartered in Horsham, PA.
